Connect With ALS Crowd on Social Media: Together We're Stronger

CONNECT - July 06, 2020

Connect With ALS Crowd on Social Media: Together We're Stronger ALS Crowd provides numerous ways to connect with other patients, caregivers, medical prof... Read More

Sleep and ALS

For people with Amyotrophic Lateral Sclerosis, sleeping is a stressful time. Both patient and caregiver suffer from sleep disturbances which are common among pa... Read More

Pimozide May Provide Better Quality of Life for ALS patients

Pimozide is a drug currently being used to suppress the physical (motor) and vocal (phonic) symptoms of tics when these symptoms interfere with daily life ... Read More

Genetic Mutation Affecting Proteins Could Cause ALS

ALS NEWS - June 14, 2020

  Over 5,000 people are diagnosed with ALS each year in the United States. Amyotrophic Lateral Sclerosis is a disease that attacks the very roots of hum... Read More

It is time to ACT against ALS!

ALS NEWS - June 10, 2020

Two pieces of legislation are making their way through congress that could drastically improve the lives of those with ALS. The first is a bill intended to... Read More

How are Proteins Involved in ALS?

ALS 101 - June 08, 2020

Amyotrophic Lateral Sclerosis is a disease that attacks the very roots of human biology.   Our bodies are made up of trillions of individual cells and w... Read More

Staying positive with ALS during COVID-19

LIFE WITH ALS - June 04, 2020

The unknown of COVID-19 in itself can be a bit unnerving, but it's crucial we stay as positive as we can, especially with ALS. Added stress can cause i... Read More

Microorganism Involvement in ALS Progression

ALS NEWS - May 31, 2020

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects the motor neurons in the central nervous system. For years, researchers have bee... Read More

FDA Approves Masitinib for a Phase 3 ALS Clinical Trial

ALS NEWS - May 30, 2020

AB Science, a clinical stage pharmaceutical company, received clearance on their application to use masitinib in an upcoming 3 phase clinical trial to... Read More

FDA Gives Fast Track Status to New Drug for Potential ALS Treatment

ALS NEWS - May 27, 2020

After much research and several clinical trials on neurodegenerative diseases, good news comes from the FDA as they allow Fast Track Designation in the dev... Read More

Biomarkers in Teeth Associated with ALS

ALS NEWS - May 27, 2020

The mission to find biological markers in connection to ALS, or Amyotrophic Lateral Sclerosis is striving and thriving. A recent study has been conducted in the... Read More

$42 Million Invested in ALS Treatments

ALS NEWS - May 15, 2020

QurAlis, a corporation based in Massachusettes, Boston has invested $42 million toward the research and development of ALS treatments. This is such a ... Read More

ALS Communication Tools

LIFE WITH ALS - May 11, 2020

Communicating with ALS Without Technology Although the progression of ALS symptoms is different in each patient, most patients will need some type of communi... Read More